MMP2 and Parkinson disease: Our results suggested that microglial activation-mediated BBB disruption via MMP-2/-9 contributed to dopaminergic neurodegeneration in rotenone-treated mice, providing a novel mechanistic insight for rotenone-elicited neurotoxicity and related Parkinsonism.